Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2Stroke 1Pain 1Neoplasms, Second Primary 1Mental Disorders 1Learning Disabilities 1Feeding and Eating Disorders 1Cancer Pain 1Brain Neoplasms 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Animal Assisted Therapy × Clear all
NCT00431639 2019-04-11

Effects of Pet Therapy on Pain in Cancer Patients

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
36 enrolled

Cancer Pain, Neoplasms, Pain

NCT01441674 2014-02-14

AAT

Children's Hospitals and Clinics of Minnesota

Phase 1/2 Completed
30 enrolled

Feeding and Eating Disorders, Mental Disorders, Learning Disabilities, Neoplasms, Stroke

Data powered by HemOnc (CC BY 4.0) Colophon âš¡